Who is sponsoring NCT05581810?

NCT05581810 is sponsored by University of British Columbia.

What drugs are being tested in NCT05581810?

Interventions in NCT05581810: Cognitive Behavioural Therapy (CBT), Cognitive Rehabilitation.

What condition does NCT05581810 study?

NCT05581810 studies Mild Traumatic Brain Injury, Functional Neurological Disorder.

Is NCT05581810 still recruiting?

NCT05581810 is currently completed. Last updated 6 December 2024.

Last reviewed 2024-12-06 · How we verify

NCT05581810

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rehabilitation for Functional Memory Symptoms After Concussion

Completed NA Last updated 6 December 2024

What this trial tests

NA trial testing Cognitive Behavioural Therapy (CBT) in Mild Traumatic Brain Injury in 30 participants. Completed in 30 November 2023.

Timeline

29 November 2022

Primary endpoint
30 June 2023

30 November 2023

Quick facts

Lead sponsor	University of British Columbia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	29 November 2022
Primary completion	30 June 2023
Estimated completion	30 November 2023
Sites	10 locations across Canada

Drugs / interventions tested

Cognitive Behavioural Therapy (CBT)
Cognitive Rehabilitation

Conditions studied

Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →
Functional Neurological Disorder — all drugs for Functional Neurological Disorder →

Sponsor

University of British Columbia

Who can join

Adults 18 to 65, any sex, with Mild Traumatic Brain Injury or Functional Neurological Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the feasibility of novel cognitive behavioural therapy (CBT)-based intervention designed to improve functional memory symptoms after concussion. Participants will be randomized to CBT or an attention-matched control intervention (cognitive rehabilitation). The primary outcomes for this trial are feasibility metrics, including recruitment, patient-perceived credibility of treatment, patient adherence to treatment, therapists' compliance with the treatment protocol, and retention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Pilot feasibility randomised controlled trial of cognitive-behavioural therapy for functional cognitive disorder after concussion.
Rioux M, Mamman R, Byworth MT, Panenka WJ, et al · · 2024 · cited 8× · PMID 39410977 · DOI 10.1136/bmjno-2024-000666
<i>Taking Control of Your Functional Cognitive Symptoms: Workbook</i>-A Novel Intervention.
Cotton E, Mordecai K, McWhirter L, Cabreira V, et al · · 2026 · cited 1× · PMID 41039861 · DOI 10.1176/appi.neuropsych.20240231
Structural brain alterations and predictors of clinical improvement in functional cognitive disorder after concussion.
Westlin C, Rioux M, Lee J, Panenka W, et al · · 2026 · PMID 41496388 · DOI 10.1016/j.nicl.2025.103936

Verify or expand the search:

Other trials of Cognitive Behavioural Therapy (CBT)

Trials testing the same drug.

NCT05553197 — Intersession Processes in Psychotherapeutic Treatments Using an Ecological Momentary Assessment Approach (ISA-Bell) · NA · recruiting
NCT05044455 — Online Peer-Delivered Group CBT for PPD · NA · completed
NCT04899492 — Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Beh · NA · terminated
NCT04924010 — Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients · NA · completed
NCT04072666 — A Comparison of Brief Cognitive Behavioural Therapy (CBT) and the Attempted Suicide Short Intervention Program · NA · unknown

Other recruiting trials for Mild Traumatic Brain Injury

Currently open trials in the same condition.

NCT07246993 — Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms · NA · recruiting
NCT07356167 — Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury · NA · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting
NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
NCT06217575 — Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in Veterans · NA · recruiting

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05581810 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 6 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05581810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing